爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALC 爱尔康

盘前交易 11-25 08:07:26 EST

85.99

+0.42

+0.49%

盘前85.99

+0.000.00%

08:02 EST

最高86.24	最低85.65	成交量45.20万
今开85.96	昨收85.57	日振幅0.70%
总市值425.31亿	流通市值424.39亿	总股本4.95亿
成交额3,886万	换手率0.09%	流通股本4.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALC","market":"US","secType":"STK","nameCN":"爱尔康","latestPrice":85.99,"timestamp":1732309200000,"preClose":85.57,"halted":0,"volume":452013,"hourTrading":{"tag":"盘前","latestPrice":85.99,"preClose":85.99,"latestTime":"08:02 EST","volume":816,"amount":70125.09792,"timestamp":1732539740677},"delay":0,"floatShares":493539429,"shares":494600000,"eps":2.339349,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.42,"latestTime":"11-25 08:07:26 EST","open":85.96,"high":86.24,"low":85.6452,"amount":38855378.297801994,"amplitude":0.006951,"askPrice":86.18,"askSize":400,"bidPrice":86.1,"bidSize":200,"shortable":3,"etf":0,"ttmEps":2.339349,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732545000000},"adr":0,"adjPreClose":85.99,"adrRate":0,"dividendRate":0.003315,"preHourTrading":{"tag":"盘前","latestPrice":85.99,"preClose":85.99,"latestTime":"08:02 EST","volume":816,"amount":70125.09792,"timestamp":1732539740677},"postHourTrading":{"tag":"盘后","latestPrice":87.65,"preClose":85.99,"latestTime":"17:42 EST","volume":12168,"amount":1046484.67,"timestamp":1732315334448},"volumeRatio":0.3980130796312483,"impliedVol":0.2073,"impliedVolPercentile":0.1235},"requestUrl":"/m/hq/s/ALC","defaultTab":"news","newsList":[{"id":"2484913779","title":"爱尔康2024财年第三财季实现净利润2.63亿美元，同比增加28.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484913779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484913779?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010420,"startTime":"0","endTime":"0","summary":"11月19日，爱尔康公布财报，公告显示公司2024财年第三财季净利润为2.63亿美元，同比增加28.92%；其中营业收入为24.54亿美元，同比增加5.37%，每股基本收益为0.53美元。机构评级：截至2024年11月19日，当前有26家机构对爱尔康目标价做出预测，其中目标均价为101.43美元，其中最低目标价为85.00美元，最高目标价为116.00美元。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180044abcedefe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180044abcedefe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALC"],"gpt_icon":0},{"id":"2483529080","title":"爱尔康盘中异动 早盘大幅下跌5.17%报87.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483529080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483529080?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:00","pubTimestamp":1731427233,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时00分，爱尔康股票出现波动，股价快速下跌5.17%。截至发稿，该股报87.51美元/股，成交量96.7863万股，换手率0.20%，振幅4.85%。爱尔康股票所在的医疗设备行业中，整体跌幅为0.68%。爱尔康公司简介：爱尔康是全球领先的视力保健公司之一。爱尔康分为两个部门：视力保健和外科，视力保健包括隐形眼镜、镜片护理解决方案和一套眼部保健产品。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111300003398e421fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111300003398e421fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4198","LU2265009873.SGD","LU1804176565.USD","ALC"],"gpt_icon":0},{"id":"2477750558","title":"PPT抄电影？马斯克和华纳的Cybercab被告上法庭","url":"https://stock-news.laohu8.com/highlight/detail?id=2477750558","media":"观察者网","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477750558?lang=zh_cn&edition=full","pubTime":"2024-10-22 12:59","pubTimestamp":1729573180,"startTime":"0","endTime":"0","summary":"Alcon指控称，在特斯拉的自动驾驶出租车CyberCab展示会上，使用了模仿银翼杀手2049的概念图设计，尽管爱尔康拒绝了华纳兄弟探索公司提出的使用相关素材的请求。当时，特斯拉等要求从电影中提取\"一个标志性的静态图像\"，从而让华纳兄弟探索工作室能在Robo Taxi发布日宣传Cybercab。特斯拉、马斯克和华纳兄弟等涉诉方尚未对爱尔康的诉讼发表意见。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221301269f5572f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221301269f5572f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823414478.USD","ALC","LU2756315664.SGD","BK4550","BK4592","LU0943347566.SGD","SG9999015986.USD","IE00BJLML261.HKD","LU1914381329.SGD","LU0348723411.USD","BK4527","LU1551013342.USD","LU0082616367.USD","PPT","IE00BSNM7G36.USD","BK4548","BK4099","SG9999015978.USD","LU1861558580.USD","LU1720051108.HKD","SG9999015952.SGD","LU1551013425.SGD","LU2213496289.HKD","LU0198837287.USD","LU1145028129.USD","LU2326559502.SGD","LU2265009873.SGD","TSLA","LU1720051017.SGD","BK4533","LU0056508442.USD","LU1548497426.USD","LU0466842654.USD","LU2602419157.SGD","LU0097036916.USD","LU0316494557.USD","LU2063271972.USD","LU0820562030.AUD","BK4551","BK4511","BK4588","LU2087621335.USD","LU0823411888.USD","LU1861559042.SGD","LU0234570918.USD","LU0053666078.USD","LU1429558221.USD","IE00BWXC8680.SGD","BK4581"],"gpt_icon":1},{"id":"2477105288","title":"Cybercab发布会再遭风波，《银翼杀手2049》制片方起诉特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2477105288","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477105288?lang=zh_cn&edition=full","pubTime":"2024-10-22 06:02","pubTimestamp":1729548174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["WMG","TSLL","LU2357305700.SGD","LU2213496289.HKD","BK4581","LU0823414478.USD","LU0234572021.USD","LU1548497426.USD","SG9999015945.SGD","LU0198837287.USD","IE00BWXC8680.SGD","LU2249611893.SGD","SG9999015952.SGD","LU0820561818.USD","WBD","BK4561","LU2087621335.USD","LU1861220033.SGD","LU1861559042.SGD","BK4099","BK4533","LU1852331112.SGD","161631","LU1551013425.SGD","LU2326559502.SGD","IE00BJLML261.HKD","IE00B1XK9C88.USD","LU1861558580.USD","LU0689472784.USD","BK4555","BK4592","LU0943347566.SGD","LU1435385759.SGD","LU1720051017.SGD","LU0820561909.HKD","LU0823411888.USD","LU0056508442.USD","LU1145028129.USD","TSLA","BK4108","BK4588","BK4551","LU0234570918.USD","LU0053666078.USD","BK4125","LU0719512351.SGD","LU0820562030.AUD","ALC","LU2063271972.USD"],"gpt_icon":0},{"id":"2476447313","title":"欧康维视生物-B午后涨超4% 与爱尔康完成股权与产品交割","url":"https://stock-news.laohu8.com/highlight/detail?id=2476447313","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476447313?lang=zh_cn&edition=full","pubTime":"2024-10-18 13:19","pubTimestamp":1729228740,"startTime":"0","endTime":"0","summary":"欧康维视生物-B午后上涨4.39%，现报6.18港元，成交额507.15万港元。10月17日，欧康维视生物-B宣布，经2024年第一次临时股东大会审议通过，公司与全球眼健康领域的引领者Alcon Inc．（简称“爱尔康”）成功完成了股权与产品交割。根据协议，欧康维视从爱尔康获得了8款产品组合在中国的研发、制造和商业化领域的相关权益。有业内人士指出，此次交割的顺利完成，不仅丰富了欧康维视的产品管线，更显著增厚了公司在干眼等眼科重要细分领域的产品布局。通过收购这些产品，欧康维视预计将能够提供更全面和先进的治疗方案，进一步满足患者需求并扩大市场份额。\n\n\r\n            责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/18131944148727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01477","BK4534","BK1191","BK1574","LU2265009873.SGD","ALC","LU1804176565.USD","BK4198"],"gpt_icon":0},{"id":"2476412959","title":"港股异动 | 欧康维视生物-B(01477)涨超3% 与爱尔康完成股权与产品交割","url":"https://stock-news.laohu8.com/highlight/detail?id=2476412959","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476412959?lang=zh_cn&edition=full","pubTime":"2024-10-18 11:20","pubTimestamp":1729221627,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，欧康维视生物-B涨超3%，截至发稿，涨3.72%，报6.14港元，成交额461.25万港元。消息面上，10月17日，欧康维视生物-B宣布，经2024年第一次临时股东大会审议通过，公司与全球眼健康领域的引领者Alcon Inc.成功完成了股权与产品交割。根据协议，欧康维视从爱尔康获得了8款产品组合在中国的研发、制造和商业化领域的相关权益。通过收购这些产品，欧康维视预计将能够提供更全面和先进的治疗方案，进一步满足患者需求并扩大市场份额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","ALC","LU1804176565.USD","LU2265009873.SGD","BK4534","BK1574","BK4198","BK1191"],"gpt_icon":0},{"id":"2476119276","title":"欧康维视生物与爱尔康完成股权与产品交割 携手共拓眼科医疗蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2476119276","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476119276?lang=zh_cn&edition=full","pubTime":"2024-10-17 16:28","pubTimestamp":1729153738,"startTime":"0","endTime":"0","summary":"2024年10月17日，欧康维视生物宣布，经2024年第一次临时股东大会审议通过，公司与全球眼健康领域的引领者Alcon Inc.成功完成了股权与产品交割。根据协议，欧康维视从爱尔康获得了8款产品组合在中国的研发、制造和商业化领域的相关权益。作为此次交易的对价，欧康维视向爱尔康发行了139,159,664股股份，占总股本的16.71%，至此爱尔康成为欧康维视的最大股东之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=vW1VQ8lthd0%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1804176565.USD","ALC","BK4198","LU2265009873.SGD","BK4534"],"gpt_icon":0},{"id":"2476626183","title":"人口老龄化机遇：隐形眼镜巨头Alcon有望继续飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2476626183","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476626183?lang=zh_cn&edition=full","pubTime":"2024-10-17 08:10","pubTimestamp":1729123802,"startTime":"0","endTime":"0","summary":"根据Thornburg Investment Management的投资组合经理Emily Leveille，Alcon为投资者提供了利用社会老龄化带来的隐形眼镜和白内障手术需求增长的机会。她称Alcon是隐形眼镜市场的领导者，该市场稳定且具有定价权。除此之外，Leveille表示，白内障手术设备市场进入壁垒较高，年增长率为4个百分点。她提到，这种创新力与Alcon的药用眼药水业务有关。Alcon在美国上市的股票继2023年上涨14%之后，今年已经上涨了近24%。","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2024/10/weixin/one_20241017081021249.png","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2024/10/weixin/one_20241017081021249.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/10/17081044088171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["ALC","LU2265009873.SGD","LU1804176565.USD","BK4534","BK4198"],"gpt_icon":0},{"id":"2472834376","title":"爱尔康跌0.18% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2472834376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472834376?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:36","pubTimestamp":1727789794,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时36分，爱尔康股票出现波动，股价快速下挫0.18%。截至发稿，该股报99.89美元/股，成交量3.4985万股，换手率0.01%，振幅0.58%。爱尔康股票所在的医疗设备行业中，整体涨幅为0.27%。爱尔康公司简介：爱尔康是全球领先的视力保健公司之一。爱尔康凭借 Dailies、Total1 和 Air Optix 等品牌控制着美国隐形眼镜市场的四分之一。爱尔康拥有世界上最大的眼科手术设备安装基地之一。消息层面，截至21时36分，爱尔康股票正面舆情新闻比例83.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001213635ab674ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001213635ab674ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALC","LU1804176565.USD","LU2265009873.SGD","BK4534","BK4198"],"gpt_icon":0},{"id":"2471831633","title":"爱尔康涨0.48% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2471831633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471831633?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:31","pubTimestamp":1727703082,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时31分，爱尔康股票出现异动，股价快速上涨0.48%。截至发稿，该股报100.12美元/股，成交量2.0518万股，换手率0.00%，振幅0.18%。爱尔康股票所在的医疗设备行业中，整体涨幅为0.18%。爱尔康拥有世界上最大的眼科手术设备安装基地之一。消息层面，截至21时31分，爱尔康股票正面舆情新闻比例83.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302131229f215b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302131229f215b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALC","LU2265009873.SGD","LU1804176565.USD","BK4534","BK4198"],"gpt_icon":0},{"id":"2471282575","title":"港股异动 | 欧康维视生物-B(01477)涨超14% 与爱尔康达成长期战略合作 公司重磅管线快速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2471282575","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471282575?lang=zh_cn&edition=full","pubTime":"2024-09-30 14:49","pubTimestamp":1727678968,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，欧康维视生物-B盘中涨超14%，截至发稿，涨12.35%，报6.37港元，成交额4592.83万港元。消息面上，今年8月，欧康维视宣布与爱尔康达成协议，欧康维视将获得爱尔康8款眼科产品在华权益。爱尔康则将持有欧康维视16.7%股权（发行后）。今年上半年，欧康维视实现收益人民币1.676亿元，同比增长61.6%，其中，销售眼科产品所取得的收入达1.5亿元，同比增长78.1%。另外，公司重磅管线快速推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4534","LU2265009873.SGD","01477","BK4198","BK1191","ALC","LU1804176565.USD"],"gpt_icon":0},{"id":"2470108680","title":"爱尔康涨1.15% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2470108680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470108680?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:31","pubTimestamp":1727443886,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时31分，爱尔康股票出现波动，股价大幅拉升1.15%。截至发稿，该股报100.22美元/股，成交量1.583万股，换手率0.00%，振幅0.17%。爱尔康股票所在的医疗设备行业中，整体涨幅为0.18%。爱尔康公司简介：爱尔康是全球领先的视力保健公司之一。爱尔康凭借 Dailies、Total1 和 Air Optix 等品牌控制着美国隐形眼镜市场的四分之一。爱尔康拥有世界上最大的眼科手术设备安装基地之一。消息层面，截至21时31分，爱尔康股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272131279f1af979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272131279f1af979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALC","BK4198","BK4534","LU2265009873.SGD","LU1804176565.USD"],"gpt_icon":0},{"id":"2470657042","title":"爱尔康刘泓：期待在眼科领域与河南深化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2470657042","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470657042?lang=zh_cn&edition=full","pubTime":"2024-09-25 22:00","pubTimestamp":1727272819,"startTime":"0","endTime":"0","summary":"目前，爱尔康正深化在华战略，加速本土化进程。期待爱尔康与河南有更深入的合作。近年来，河南省高度重视眼科发展，在眼科领域布局频频。针对刘泓的发言，河南省人民政府参事、郑州航空港经济综合实验区生物医药大健康指挥部指挥长花亚伟表示，目前中原医科城正着力打造“中原眼谷”，希望爱尔康积极加入“中原眼谷”建设，为河南眼科领域发展做出爱尔康的贡献。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925221259957d1981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925221259957d1981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2265009873.SGD","BK4198","BK4534","LU1804176565.USD","ALC"],"gpt_icon":0},{"id":"2461347285","title":"爱尔康2024财年第二财季实现净利润2.23亿美元，同比增加31.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461347285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461347285?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:01","pubTimestamp":1724342484,"startTime":"0","endTime":"0","summary":"8月23日，爱尔康公布财报，公告显示公司2024财年第二财季净利润为2.23亿美元，同比增加31.95%；其中营业收入为24.96亿美元，同比增加3.06%，每股基本收益为0.45美元。机构评级：截至2024年8月23日，当前有25家机构对爱尔康目标价做出预测，其中目标均价为101.23美元，其中最低目标价为72.48美元，最高目标价为116.00美元。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082300015995b4b1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082300015995b4b1ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALC"],"gpt_icon":0},{"id":"2461434675","title":"Baird：维持Alcon(ALC.US)评级 目标价由104.00美元调整至110.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461434675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461434675?lang=zh_cn&edition=full","pubTime":"2024-08-22 22:25","pubTimestamp":1724336752,"startTime":"0","endTime":"0","summary":"Baird：维持Alcon(ALC.US)评级，由优于大市调整至优于大市评级,目标价由104.00美元调整至110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082222373395b480a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082222373395b480a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALC"],"gpt_icon":0},{"id":"2461350088","title":"美国研究综述-阿迪生物科学公司、塔吉特公司、伟世通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2461350088","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461350088?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:07","pubTimestamp":1724310430,"startTime":"0","endTime":"0","summary":"    路透8月22日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Aadi Bioscience、Target 和伟世通。要闻              * Aadi Bioscience Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有             * 塔吉特公司  ：杰富瑞将目标价从 190 美元上调至 195 美元             * 伟世通公司   ：加拿大皇家银行将目标价从144美元下调至129美元以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VC","IE0002270589.USD","PDS","HAL","INMB","FTI","LU0878866978.SGD","TS","WFRD","M","CTRE","WHD","SNPS","WOLF","SLB","IE00BLSP4239.USD","LU0154245673.USD","LU0251142724.SGD","LU0823411888.USD","LU1951198990.SGD","BKR","PTEN","COTY","BK4548","OIS","AADI","TGT","TJX","A","ACDC","GTLS","KLXE","RNGR","TOL","S","CHX","LU1951200564.SGD","OKE","SGXZ23171101.USD","DY","LU1244550577.SGD","WTTR","ALHC","LU0985489474.SGD","ALC","URBN","LU1988902786.USD"],"gpt_icon":1},{"id":"2459497782","title":"港股异动 | 欧康维视生物-B(01477)涨超6% 与爱尔康完成重要战略合作 公司商业化进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2459497782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459497782?lang=zh_cn&edition=full","pubTime":"2024-08-15 14:26","pubTimestamp":1723703169,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，欧康维视生物-B涨超6%，截至发稿，涨5.83%，报6.35港元，成交额1050.44万港元。消息面上，近日，欧康维视宣布与爱尔康达成协议，欧康维视将获得爱尔康8款眼科产品在华权益。爱尔康则将持有欧康维视16.7%股权（发行后）。今年上半年，欧康维视实现收益人民币1.676亿元，同比增长61.6%，其中，销售眼科产品所取得的收入达1.5亿元，同比增长78.1%；经调整净亏损额同比收窄20.0%。中金指出，公司商业化进展顺利，销售团队持续扩充。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","LU2265009873.SGD","BK4198","BK1191","BK4534","LU1804176565.USD","ALC","BK1574"],"gpt_icon":0},{"id":"2459010918","title":"中国药企“联姻”全球眼科龙头始末","url":"https://stock-news.laohu8.com/highlight/detail?id=2459010918","media":"信风TradeWind","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459010918?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:17","pubTimestamp":1723648668,"startTime":"0","endTime":"0","summary":"8月13日，欧康维视生物宣布计划引进全球眼科龙头Alcon旗下8款干眼症治疗和手术用滴眼液产品组合的在华的相关权益。不仅如此，爱尔康此次基本将在华眼科药物权益打包“出售”给了欧康维视生物，但并未在欧康维视生物的董事会中占有席位。国内市场方面，据刘晔透露，爱尔康在华的眼科药物商业化团队将全部并入欧康维视生物，双方将共同开拓市场。作为全球眼科的龙头企业，爱尔康的业务遍布全球56个国家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142329179f2af80a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142329179f2af80a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU2265009873.SGD","01477","BK4198","ALC","LU1804176565.USD"],"gpt_icon":0},{"id":"2459990491","title":"欧康维视“牵手”全球眼科龙头爱尔康，引进8款药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2459990491","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459990491?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:59","pubTimestamp":1723557593,"startTime":"0","endTime":"0","summary":"加码干眼症。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/5bb94d67-b6f5-49c0-9aa4-8daac376a570.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/5bb94d67-b6f5-49c0-9aa4-8daac376a570.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3723927","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3723927","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU2265009873.SGD","BK4198","BK4534","LU1804176565.USD","ALC"],"gpt_icon":0},{"id":"2459739889","title":"眼科产品收益大增，欧康维视上半年减亏0.25亿元，爱尔康将入股成为主要股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2459739889","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459739889?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:13","pubTimestamp":1723544032,"startTime":"0","endTime":"0","summary":"2020年7月，欧康维视在港股上市。财报数据显示，今年上半年，欧康维视的销售及营销开支为1.099亿元，上年同期为1.147亿元。半年报显示，欧康维视共有25种眼前及眼后段药物资产，涵盖所有主要的眼睛前部及后部疾病。股份发行完成后，爱尔康将成为公司的主要股东。此次交易将进一步拓展欧康维视在干眼症领域的布局。在持续扩大布局后，市场仍在等待欧康维视的扭亏节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131814009f2720c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131814009f2720c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4198","LU1804176565.USD","LU2265009873.SGD","ALC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alcon.com","stockEarnings":[{"period":"1week","weight":0.0101},{"period":"1month","weight":-0.0901},{"period":"3month","weight":-0.1051},{"period":"6month","weight":-0.0385},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1007}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alcon Inc.最初于1971年在瑞士注册成立。Alcon是一家以研发为主导的全球医疗专业公司，主要专注于眼部护理。该公司开发，生产和销售药品，手术设备和设备以及消费者眼部护理产品。该公司广泛的产品系列是眼科行业中最强大的产品组合之一，在所有主要产品类别中都拥有高质量和技术先进的产品。该公司相信它拥有全球任何公司眼科研究和开发的最大承诺。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.013735},{"month":2,"riseRate":0.6,"avgChangeRate":0.005925},{"month":3,"riseRate":0.6,"avgChangeRate":-0.019148},{"month":4,"riseRate":0.6,"avgChangeRate":-0.005889},{"month":5,"riseRate":0.666667,"avgChangeRate":0.065443},{"month":6,"riseRate":0.5,"avgChangeRate":-0.004565},{"month":7,"riseRate":0.833333,"avgChangeRate":0.039359},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002678},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.039338},{"month":10,"riseRate":0.5,"avgChangeRate":-0.010311},{"month":11,"riseRate":0.5,"avgChangeRate":0.02235},{"month":12,"riseRate":0.8,"avgChangeRate":0.037954}],"exchange":"NYSE","name":"爱尔康","nameEN":"Alcon Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔康(ALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔康,ALC,爱尔康股票,爱尔康股票老虎,爱尔康股票老虎国际,爱尔康行情,爱尔康股票行情,爱尔康股价,爱尔康股市,爱尔康股票价格,爱尔康股票交易,爱尔康股票购买,爱尔康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔康(ALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}